SEP 29, 2020 6:10 AM PDT

What We Call Parkinson's Disease May Actually be Two Distinct Disorders

WRITTEN BY: Carmen Leitch

Researchers have used imaging tools to show that Parkinson's disease may actually be two different diseases, one that starts in the brain while the other begins in the intestines. This can explain why patients can report very different symptoms and may improve therapeutic options for people that suffer from Parkinson's. The findings have been reported in the journal Brain.

Image credit: Pixabay

"With the help of advanced scanning techniques, we've shown that Parkinson's disease can be divided into two variants, which start in different places in the body. For some patients, the disease starts in the intestines and spreads from there to the brain through neural connections. For others, the disease starts in the brain and spreads to the intestines and other organs such as the heart," said study author Per Borghammer of Aarhus University Hospital, Denmark.

In Parkinson's disease patients, the brain degenerates as a dangerous protein called alpha-synuclein accumulates. The nerve damage disrupts movement in patients.

PET and MRI imaging tools were used to assess Parkinson's disease patients as well as people who were thought to be at high risk for developing it. The work showed that there was damage in the dopamine systems in the brains of some patients prior to intestine or heart damage. In other patients, there was damage in the intestine's and heart's nerve networks before any damage appeared in the dopamine system of the brain. The findings, said Borghammer, challenge our understanding of the disease.

"Until now, many people have viewed the disease as relatively homogeneous and defined it based on the classical movement disorders. But at the same time, we've been puzzled about why there was such a big difference between patient symptoms. With this new knowledge, the different symptoms make more sense and this is also the perspective in which future research should be viewed," he said.

The scientists have referred to the two types as body-first or brain-first Parkinson's disease. They suggested that the microbiota may be of particular interest when it comes to body-first.

"It has long since been demonstrated that Parkinson's patients have a different microbiome in the intestines than healthy people, without us truly understanding the significance of this. Now that we're able to identify the two types of Parkinson's disease, we can examine the risk factors and possible genetic factors that may be different for the two types. The next step is to examine whether, for example, body-first Parkinson's disease can be treated by treating the intestines with feces transplantation or in other ways that affect the microbiome," explained Borghammer.

"The discovery of brain-first Parkinson's is a bigger challenge. This variant of the disease is probably relatively symptom-free until the movement disorder symptoms appear and the patient is diagnosed with Parkinson's. By then the patient has already lost more than half of the dopamine system, and it will therefore be more difficult to find patients early enough to be able to slow the disease," Borghammer noted.

Sources: AAAS/Eurekalert! via Aarhus University, Brain

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 16, 2020
Cell & Molecular Biology
The Cerebellum Is Far Bigger Than We Thought
AUG 16, 2020
The Cerebellum Is Far Bigger Than We Thought
Researchers are revealing more about the critical functios of the cerebellum, which is Latin for "little brain."
AUG 19, 2020
Immunology
Cancer Mutation Improves Chemo Drug Performance
AUG 19, 2020
Cancer Mutation Improves Chemo Drug Performance
When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcom ...
AUG 23, 2020
Cell & Molecular Biology
A Potential Breakthrough in Type 1 Diabetes Treatment
AUG 23, 2020
A Potential Breakthrough in Type 1 Diabetes Treatment
Salk Institute researchers created 3D cell clusters that can produce insulin, which is shown in green in their image.
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
OCT 04, 2020
Cell & Molecular Biology
Why the Effects of a Drug Depend on Who Takes It
OCT 04, 2020
Why the Effects of a Drug Depend on Who Takes It
Many drugs can have a wide range of impacts on the patients that take them; doctors often have to adjust a person's dosa ...
OCT 19, 2020
Genetics & Genomics
Early Childhood Trauma Affects Metabolism in the Next Generation
OCT 19, 2020
Early Childhood Trauma Affects Metabolism in the Next Generation
Traumatic experiences can have a lasting impact, and kids that suffer through them can feel the effects for a lifetime. ...
Loading Comments...